Our licensed, registered clinicians specialise in weight management and oversee every treatment, giving you safe, reliable support throughout your journey
Potential Applications in Healthcare Settings 01 As clinical trials progress and positive results emerge, NA-931 holds promise to become a key therapeutic agent for obesity and related metabolic disorders in medical institutions
Wake up to a smoother and softer-looking pout
For instance, in June 2024, the Therapeutics Goods Administration (TGA) of Australian announced amendments to the Therapeutics Goods Regulations 1990 (Schedule 5, item 6) under which compounded GLP-1 RA products and medicines will no longer compounded by pharmacists and supplied to patients effective from October 1, 2024
Recent advances in primary and secondary prevention of atherosclerotic stroke
A good candidate for Contrave is someone who has struggled to lose weight through diet and exercise alone and is seeking additional support in their weight loss journey